In the past year, the marijuana industry has been a monster in terms of growth. Many investors have decided to jump right in to this new industry with profits hitting all time highs. It is not out of the ordinary to see some marijuana stocks that have doubled or even tripled in value over the past 12 months.

With an industry that is expected to grow from around $5 billion to a whopping $17 billion by 2021, why not jump right in? Those numbers put the industry at a 300% legal sales growth with opportunities unexplored including new states legalizing the drug, organic growth within legal states, and the opportunity to move the black market into legal channels. The opportunity for marijuana is incredible. Here’s four stocks that have grown a substantial 10% in the last week.

1.Cara Therapeutics (+12.8%)
A market favorite for its large, quick, gains, Cara Therapeutics (NASDAQ: CARA) had unfortunately lost more than half of its market value in a two-week timeframe. Last week, Cara unexpectedly found its place and grew almost 13%.

One major piece of news seems to be the cause here. On July 12th Cara announced it data for its phase 1 trial of oral CR845, a treatment for pain and pruritus (itching) in patients with chronic kidney disease who are undergoing hemodialysis. All of the data was very promising.

2. Aphria (13.2%)
One of the Canadian giants in the industry, Aphria (NASDAQOTH: APHQF) had an exceptional week, growing over 13%. Many speculate that this is due to its fourth-quarter and full-year results for the fiscal year of 2017. The company did report a loss however in its fourth-quarter report but the $5.5 million is all accounted for in the companies new plans for expansion and growth. The largest strong spot of their report was a 25% decrease in all-in cash costs from 2016 to $1.31 a gram. As demand rises and costs fall, the company is expected to continue this growth trend.

3. Aurora Cannabis (+16.1%)
The largest gainer of the week among marijuana stocks with a 16% gain, was Aurora Cannabis (NASDAQOTH: ACBFF), yet another Canadian medical-cannabis producer. Aurora happens to be one of Aphria’s largest competitors. Aurora recently announced that it is in the process of developing what they call ‘the Aurora Sky project’. The project is essentially an 800,000 square foot facility that the company claims will be the most advanced and automated in the world. It is scheduled to be completed early next year.

One of the main reasons why Aurora skyrocket is an announcement that it would move from the TSX Venture Exchange to the much larger Toronto Stock Exchange. This move comes from a significant boost in the companies market cap over the past year, and could be just the jump investors need to get their feet wet.

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published.

You May Also Like

1 Biotech Stock That Could Have Investors Looking At A Billion-Dollar Opportunity

The recent $12 billion acquisition of Kite Pharma, Inc. by big-pharma giant,…